Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the publication of Phase 1/2 ...

US agriculture major Corteva Agriscience is accelerating its biologicals push in India, focusing on biocontrols and ...

Corteva Agriscience accelerates its biologicals push in India, focusing on biocontrols and biostimulants due to climate ...

Corteva accelerates its biological solutions in India to combat climate change, pest resistance, and enhance food security for farmers.

Iran and Uzbekistan will support the implementation of 10 research projects following a joint call by the Iran National ...

Cholesterol meds—taking by millions of Americans every day—often come with a lifelong prescription, adding out-of-pocket ...

A research team led by Professor Lee Hyun-ji (co-first authors Kim Sang-hoon, Kim Ji-eun, Joo Sung-jin, PhD student at Korea University Medical School, and co-corresponding author Lee Hyun-ji) ...

These science fiction masterpieces predicted aspects of the future with eerie uncanniness and left a lasting impression.

They want to escape from regulation and ‘failing’ democracy — but are they more opportunistic than libertarian?

The first 100 bases of many genes show excess mutations, revealing a major genomic weak spot that shapes disease risk and ...

Data featured in an ASH oral presentation; LINKER-MM4 is the first clinical trial to evaluate a BCMAxCD3 bispecific monotherapy in NDMM and is part of a broad clinical development program evaluating ...